Anticancer activity of 3-O-acyl and alkyl-(-)-epicatechin derivatives. 2004

Ki Duk Park, and Sul Gi Lee, and Sung Uk Kim, and Sung Han Kim, and Won Suck Sun, and Sung Jin Cho, and Do Hyeon Jeong
Laboratory of Cellular Function Modulator, Korea Research Institute of Bioscience and Biotechnology, Yusung, Taejon 305-333, Korea. pkduck75@hanmail.net

By changing the structure or replacing the gallate group of (-)-ECG, 3-O-acyl and alkyl-(-)-epicatechin derivatives were synthesized to be screen as anticancer agents using the MTT assay in vitro against cancer cell lines (PC3, SKOV3, U373MG). 3-O-Acyl and alkyl-(-)-epicatechin derivatives (4-25) exhibited better anticancer activity than (-)-ECG and specially, compounds 6-8, 17-19, which were modified aliphatic chains with moderate sizes (C8-C12) showed strong anticancer activity (IC50=6.4-31.2 microM). The introduction of an alkyloxy group on 3-O-hydroxyl instead of an acyloxy group significantly enhanced inhibitory activity. Consequently, the compound that showed the most potency as anticancer agents were 3-O-decyl-(-)-epicatechin (18) (IC50=8.9, 7.9, 6.4 microM against PC3, SKOV3, U373MG, respectively), which modified the appropriate lipophilic group on the C-3 hydroxyl as an alkyloxy group.

UI MeSH Term Description Entries
D002392 Catechin An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms. Catechinic Acid,Catechuic Acid,(+)-Catechin,(+)-Cyanidanol,(+)-Cyanidanol-3,(-)-Epicatechin,(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol,2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-,3,3',4',5,7-Flavanpentol,Catergen,Cianidanol,Cyanidanol-3,Epicatechin,KB-53,Z 7300,Zyma,Cyanidanol 3,KB 53,KB53
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D028241 Camellia sinensis Camellia sinensis L. (formerly Thea sinensis) is an evergreen Asiatic shrub of the THEACEAE family. The infusion of leaves of this plant is used as Oriental TEA which contains CAFFEINE; THEOPHYLLINE; and epigallocatechin gallate. Thea sinensis,Camellia sinenses,Thea sinenses,sinensis, Camellia,sinensis, Thea

Related Publications

Ki Duk Park, and Sul Gi Lee, and Sung Uk Kim, and Sung Han Kim, and Won Suck Sun, and Sung Jin Cho, and Do Hyeon Jeong
March 2004, Planta medica,
Ki Duk Park, and Sul Gi Lee, and Sung Uk Kim, and Sung Han Kim, and Won Suck Sun, and Sung Jin Cho, and Do Hyeon Jeong
January 2001, European journal of medicinal chemistry,
Ki Duk Park, and Sul Gi Lee, and Sung Uk Kim, and Sung Han Kim, and Won Suck Sun, and Sung Jin Cho, and Do Hyeon Jeong
January 2018, Anti-cancer agents in medicinal chemistry,
Ki Duk Park, and Sul Gi Lee, and Sung Uk Kim, and Sung Han Kim, and Won Suck Sun, and Sung Jin Cho, and Do Hyeon Jeong
February 2019, Molecules (Basel, Switzerland),
Ki Duk Park, and Sul Gi Lee, and Sung Uk Kim, and Sung Han Kim, and Won Suck Sun, and Sung Jin Cho, and Do Hyeon Jeong
August 1998, Die Pharmazie,
Ki Duk Park, and Sul Gi Lee, and Sung Uk Kim, and Sung Han Kim, and Won Suck Sun, and Sung Jin Cho, and Do Hyeon Jeong
February 2006, Bioorganic & medicinal chemistry letters,
Ki Duk Park, and Sul Gi Lee, and Sung Uk Kim, and Sung Han Kim, and Won Suck Sun, and Sung Jin Cho, and Do Hyeon Jeong
October 2009, Journal of Asian natural products research,
Ki Duk Park, and Sul Gi Lee, and Sung Uk Kim, and Sung Han Kim, and Won Suck Sun, and Sung Jin Cho, and Do Hyeon Jeong
June 2016, European journal of medicinal chemistry,
Ki Duk Park, and Sul Gi Lee, and Sung Uk Kim, and Sung Han Kim, and Won Suck Sun, and Sung Jin Cho, and Do Hyeon Jeong
December 2015, Bioorganic chemistry,
Ki Duk Park, and Sul Gi Lee, and Sung Uk Kim, and Sung Han Kim, and Won Suck Sun, and Sung Jin Cho, and Do Hyeon Jeong
July 1976, The Journal of antibiotics,
Copied contents to your clipboard!